Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
AflacLL1901 (CHOA-AML)
- Status
- TERMINATED
- Phase
- PHASE2
National Cancer Institute "Cancer Moonshot Biobank"
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia: a Prospective Multicentric Study.
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- N/A
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- Status
- RECRUITING
- Phase
- PHASE3
Immunophenotyping and Xist Gene in AML
- Status
- UNKNOWN
- Phase
- N/A
BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of TAS1440 With ATRA in Subjects With r/r AML
- Status
- TERMINATED
- Phase
- PHASE1
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE2
CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
Testing Nivolumab in Combination With Decitabine and Venetoclax in Patients With Newly Diagnosed TP53 Gene Mutated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Study of HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukemia/Neoplasms
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Venetoclax in Combination With Azacytidine in AML Patients Selected Using Ex Vivo Drug Sensitivity Screening
- Status
- COMPLETED
- Phase
- PHASE2
AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Analysis of T Cell Metabolism in Acute Myeloid Leukemia Patients
- Status
- COMPLETED
- Phase
- N/A
CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3